A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/29 (2006.01) A61K 31/59 (2006.01) A61K 33/06 (2006.01)
Patent
CA 2621264
The present invention is directed to novel methods of treating a subject with a bone deficit disorder. The methods generally include administering to a subject in need thereof a pharmaceutically acceptable formulation comprising a parathyroid hormone (PTH) peptide analogue in a daily dose of 2 µg to 60 µg, wherein said PTH peptide analogue has a reduced phospholipase-C activity and maintains adenylate cyclase activity.
La présente concerne de nouveaux procédés de traitement d'individus atteints d'un trouble du déficit osseux. Lesdits procédés impliquent de manière générale d'administrer, à un individu le nécessitant, une formulation pharmaceutiquement acceptable comprenant un analogue peptidique d'hormone parathyroïdienne (PTH) en une dose quotidienne allant de 2 µg à 60 µg, ledit analogue faisant preuve d'une activité de phospholipase-C réduite et d'une activité d'adénylate cyclase stable.
Ridout & Maybee Llp
Zelos Therapeutics Inc.
LandOfFree
Parathyroid hormone analogues and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Parathyroid hormone analogues and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parathyroid hormone analogues and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1981831